Ryan Whitaker

1.4k total citations
22 papers, 1.1k citations indexed

About

Ryan Whitaker is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ryan Whitaker has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Ryan Whitaker's work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Mitochondrial Function and Pathology (3 papers). Ryan Whitaker is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Mitochondrial Function and Pathology (3 papers). Ryan Whitaker collaborates with scholars based in United States, Israel and Canada. Ryan Whitaker's co-authors include Rick G. Schnellmann, L. Jay Stallons, Craig C. Beeson, Rick G. Schnellmann, Paloma H. Giangrande, James O McNamara, Gregory S. Thomas, Xiuying Liu, David K. Meyerholz and Anton P. McCaffrey and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Ryan Whitaker

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Whitaker United States 9 725 177 126 101 85 22 1.1k
Jianping Peng China 20 569 0.8× 127 0.7× 342 2.7× 58 0.6× 122 1.4× 77 1.4k
Zhengguang Guo China 20 622 0.9× 72 0.4× 167 1.3× 112 1.1× 61 0.7× 71 1.2k
Doris Kloor Germany 19 476 0.7× 59 0.3× 87 0.7× 64 0.6× 69 0.8× 35 1.2k
Mien T.X. Nguyen United States 13 575 0.8× 146 0.8× 59 0.5× 56 0.6× 37 0.4× 14 1.0k
Sang‐Ho Kwon United States 19 582 0.8× 125 0.7× 194 1.5× 57 0.6× 48 0.6× 44 884
Chuanjiang Li China 10 427 0.6× 70 0.4× 255 2.0× 44 0.4× 195 2.3× 39 947
Zena Huang China 12 360 0.5× 109 0.6× 73 0.6× 49 0.5× 46 0.5× 26 621
Shixuan Wang China 22 932 1.3× 521 2.9× 106 0.8× 66 0.7× 77 0.9× 62 1.6k
Ruixia Ma China 15 379 0.5× 232 1.3× 209 1.7× 31 0.3× 68 0.8× 51 819
Gangqi Wang Netherlands 13 342 0.5× 132 0.7× 68 0.5× 63 0.6× 59 0.7× 28 758

Countries citing papers authored by Ryan Whitaker

Since Specialization
Citations

This map shows the geographic impact of Ryan Whitaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Whitaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Whitaker more than expected).

Fields of papers citing papers by Ryan Whitaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Whitaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Whitaker. The network helps show where Ryan Whitaker may publish in the future.

Co-authorship network of co-authors of Ryan Whitaker

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Whitaker. A scholar is included among the top collaborators of Ryan Whitaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Whitaker. Ryan Whitaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jaclyn, Tianyi Sun, Dandan Liu, et al.. (2025). Circulating Tumor Tissue‐Modified‐Viral HPV DNA and Correlations With Disease Burden in Oropharyngeal Cancer. Otolaryngology. 173(4). 911–918.
2.
Whitaker, Ryan, et al.. (2025). Stereotactic Radiosurgery to the Nucleus Accumbens: A Dosimetric Feasibility Study. Cureus. 17(7). e88231–e88231.
3.
Sharma, Rahul K., Kyle Mannion, Robert J. Sinard, et al.. (2025). Impact of Postoperative Radiation Therapy Delay and Treatment Facility Location on Survival in Head and Neck Cancer Patients. Head & Neck. 47(7). 1807–1815.
4.
Mooradian, Meghan J., et al.. (2024). Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung Cancer. JAMA Network Open. 7(4). e247542–e247542. 7 indexed citations
5.
6.
Yalamanchi, Pratyusha, Barbara Murphy, Natalie A. Lockney, et al.. (2024). Visual pathology reports for improved collaboration at multidisciplinary head and neck tumor board. Head & Neck. 47(2). 452–462. 2 indexed citations
7.
Whitaker, Ryan & Evan C. Osmundson. (2023). SiCARIO: A Phase I/II Study of Split-Course Adaptive Radioimmunotherapy for the Treatment of Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Using Adaptive Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 118(1). e15–e15.
8.
Whitaker, Ryan & Evan C. Osmundson. (2021). Identification of Clinical Predictors of Benefit of Palliative Thoracic Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 111(3). e492–e492.
9.
Whitaker, Ryan & Evan C. Osmundson. (2021). Prolonged Time of Lung Collapse Associated With Decreased Recovery of Functional Lung Following Palliative Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 111(3). S118–S119. 1 indexed citations
10.
Khattab, Mohamed H., Alexander D. Sherry, Ryan Whitaker, et al.. (2019). A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma. Neurosurgery. 85(6). E1078–E1083. 6 indexed citations
11.
12.
Gibbs, Whitney S., et al.. (2016). Striatal Mitochondrial Disruption following Severe Traumatic Brain Injury. Journal of Neurotrauma. 34(2). 487–494. 22 indexed citations
13.
Whitaker, Ryan, L. Jay Stallons, Joseph L. Alge, et al.. (2015). Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury. Kidney International. 88(6). 1336–1344. 81 indexed citations
14.
Whitaker, Ryan, Midhun C. Korrapati, L. Jay Stallons, et al.. (2015). Urinary ATP Synthase Subunit β Is a Novel Biomarker of Renal Mitochondrial Dysfunction in Acute Kidney Injury. Toxicological Sciences. 145(1). 108–117. 12 indexed citations
15.
Garrett, Sara M., Ryan Whitaker, Craig C. Beeson, & Rick G. Schnellmann. (2014). Agonism of the 5-Hydroxytryptamine 1F Receptor Promotes Mitochondrial Biogenesis and Recovery from Acute Kidney Injury. Journal of Pharmacology and Experimental Therapeutics. 350(2). 257–264. 61 indexed citations
16.
Stallons, L. Jay, Ryan Whitaker, & Rick G. Schnellmann. (2013). Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis. Toxicology Letters. 224(3). 326–332. 114 indexed citations
17.
Whitaker, Ryan, Lauren Wills, L. Jay Stallons, & Rick G. Schnellmann. (2013). cGMP-Selective Phosphodiesterase Inhibitors Stimulate Mitochondrial Biogenesis and Promote Recovery from Acute Kidney Injury. Journal of Pharmacology and Experimental Therapeutics. 347(3). 626–634. 80 indexed citations
18.
Smith, Matthew A., Campbell McInnes, Ryan Whitaker, et al.. (2012). Calpain 10 Homology Modeling with CYGAK and Increased Lipophilicity Leads to Greater Potency and Efficacy in Cells. ACS Chemical Biology. 7(8). 1410–1419. 3 indexed citations
19.
Dassie, Justin P., Xiuying Liu, Gregory S. Thomas, et al.. (2009). Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nature Biotechnology. 27(9). 839–846. 474 indexed citations
20.
Whitaker, Ryan, et al.. (2004). Analysis of a Near-Vacuum Hall Thruster. 42nd AIAA Aerospace Sciences Meeting and Exhibit. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianping Peng Breakdown of academic impact, for papers by Zhengguang Guo Breakdown of academic impact, for papers by Doris Kloor Breakdown of academic impact, for papers by Mien T.X. Nguyen Breakdown of academic impact, for papers by Sang‐Ho Kwon Breakdown of academic impact, for papers by Chuanjiang Li Breakdown of academic impact, for papers by Zena Huang Breakdown of academic impact, for papers by Shixuan Wang Breakdown of academic impact, for papers by Ruixia Ma Breakdown of academic impact, for papers by Gangqi Wang
Rankless by CCL
2026